SkinBioTherapeutics Plc

(LSE) SBTX

Current Price$9.85

Market Cap$2.55B

Since IPO (2017)-26%

5 Year-100%

1 Year-100%

1 Month-99%

SkinBioTherapeutics Plc Financials at a Glance

Market Cap

$2.55B

Revenue (TTM)

$5.85M

Net Income (TTM)

$3.57M

EPS (TTM)

$-0.33

P/E Ratio

-29.85

Dividend

$0.00

Beta (Volatility)

0.05 (Low)

Dividend

$0.00

Beta (Volatility)

0.05 (Low)

Price

$9.85

Volume

2,054,113

Open

$10.00

Price

$9.85

Volume

2,054,113

Open

$10.00

Previous Close

$9.85

Daily Range

$8.38 - $8.38

52-Week Range

$5.00 - $22.64

Dividend

$0.00

Beta (Volatility)

0.05 (Low)

Price

$9.85

Volume

2,054,113

Open

$10.00

Previous Close

$9.85

Daily Range

$8.38 - $8.38

52-Week Range

$5.00 - $22.64

SBTX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About SkinBioTherapeutics Plc

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Stuart John Ashman

Website

www.skinbiotherapeutics.com

Headquarters

Newcastle upon Tyne, NE4 5TF, GB

SBTX Financials

Key Financial Metrics (TTM)

Gross Margin

58%

Operating Margin

-24%

Net Income Margin

-15%

Return on Equity

-11%

Return on Capital

-11%

Return on Assets

-6%

Earnings Yield

-3.35%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.55B

Shares Outstanding

259.17M

Volume

2.05M

Avg. Volume

4.15M

Financials (TTM)

Gross Profit

$2.71M

Operating Income

$826.79K

EBITDA

$196.54K

Operating Cash Flow

$1.30M

Capital Expenditure

$6.30K

Free Cash Flow

$1.30M

Cash & ST Invst.

$4.78M

Total Debt

$993.47K

SkinBioTherapeutics Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2024YOY CHG

Revenue

$3.06M

+5459.3%

Gross Profit

$1.83M

+32490.0%

Gross Margin

59.71%

N/A

Market Cap

$2.55B

N/A

Market Cap/Employee

$170.19M

N/A

Employees

N/A

Net Income

$337.85K

+121.8%

EBITDA

$657.80K

+140.6%

Quarterly Fundamentals

Name

Q4 2024YOY CHG

Net Cash

$3.79M

+212.6%

Accounts Receivable

$1.41M

+10346.8%

Inventory

$800.15K

+2288.7%

Long Term Debt

$881.35K

+1166.3%

Short Term Debt

$224.22K

+622.3%

Return on Assets

-5.74%

N/A

Return on Invested Capital

-10.54%

N/A

Free Cash Flow

$498.50K

+72.1%

Operating Cash Flow

$494.84K

+70.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CREO.LCreo Medical Limited

CREO.LCreo Medical Limited$12.63-2.88%

HVO.LhVIVO plc

HVO.LhVIVO plc$7.30-2.67%

KOO.LKooth plc

KOO.LKooth plc$128.50+0.00%

HEMO.LHemogenyx Pharmaceuticals Plc

HEMO.LHemogenyx Pharmaceuticals Plc$676.50+0.22%

POLB.LPoolbeg Pharma PLC

POLB.LPoolbeg Pharma PLC$4.30-3.37%

SAR.LSareum Holdings plc

SAR.LSareum Holdings plc$20.25-1.22%

IMM.LImmuPharma plc

IMM.LImmuPharma plc$4.14+2.22%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

RIVNRivian Automotive

RIVNRivian Automotive$15.02-0.08%

Questions About SBTX

What is the current price of SkinBioTherapeutics Plc?

SkinBioTherapeutics Plc is trading at GBX 9.85 per share.

What is the 52-week range for SkinBioTherapeutics Plc?

Over the past 52 weeks, SkinBioTherapeutics Plc has traded between GBX 5.00 and GBX 22.64.

How much debt does SkinBioTherapeutics Plc have?

As of the most recent reporting period, SkinBioTherapeutics Plc reported total debt of $993,466.

How much cash does SkinBioTherapeutics Plc have on hand?

SkinBioTherapeutics Plc reported $4.78M in cash and cash equivalents in its most recent financial results.

What is SkinBioTherapeutics Plc’s dividend yield?

SkinBioTherapeutics Plc does not currently have a dividend yield.

SkinBioTherapeutics Plc

SkinBioTherapeutics Plc Financials at a Glance

SBTX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About SkinBioTherapeutics Plc

SBTX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

SkinBioTherapeutics Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SBTX

What is the current price of SkinBioTherapeutics Plc?

What is the 52-week range for SkinBioTherapeutics Plc?

How much debt does SkinBioTherapeutics Plc have?

How much cash does SkinBioTherapeutics Plc have on hand?

What is SkinBioTherapeutics Plc’s dividend yield?

Premium Investing Services